02606oam 2200697zu 450 991069835580332120210807004708.0(CKB)3450000000002101(SSID)ssj0000621018(PQKBManifestationID)11379378(PQKBTitleCode)TC0000621018(PQKBWorkID)10613546(PQKB)10657755(SSID)ssj0000620943(PQKBManifestationID)11371931(PQKBTitleCode)TC0000620943(PQKBWorkID)10630310(PQKB)11788036(WaSeSS)Innodata00029922(OCoLC)212626212(OCoLC)229155588(EXLCZ)99345000000000210120160829d2008 uy engur|||||||||||txtccrDiabetes education for children with type 1 diabetes mellitus and their families[Place of publication not identified]University of Alberta/Capital Health Evidence based Practice Center20081 online resourceEvidence report/technology assessment Hydroxyurea for the treatment of sickle cell diseaseBibliographic Level Mode of Issuance: MonographIncludes bibliographical references.Evidence report/technology assessment ;no. 166.AHRQ publication ;no. 08-E011.Sickle cell anemiaTreatmentAntineoplastic agentsTherapeutic useUreaDerivativesTherapeutic useDiabetes Mellitus, Type 1prevention & controlChildEvidence-Based MedicinemethodsOutcome Assessment, Health CarePatient Education as TopicmethodsMeta-Analysis.Sickle cell anemiaTreatmentAntineoplastic agentsTherapeutic useUreaDerivativesTherapeutic useDiabetes Mellitus, Type 1prevention & control.Child.Evidence-Based Medicinemethods.Outcome Assessment, Health Care.Patient Education as Topicmethods.Segal Jodi BJohns Hopkins University Evidence-based Practice CenterUnited States Agency for Healthcare Research and QualityPQKBBOOK9910698355803321Diabetes education for children with type 1 diabetes mellitus and their families3129500UNINA